SMTL ID : 6qhb.1 (1 other biounit)

Crystal Structure of Human Kallikrein 6 in complex with GSK578724A

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.84 Å

Oligo State

monomer

Ligands

1 x J2W: ~{N}-(4-carbamimidoylphenyl)-3-methoxy-2-oxidanyl-benzamide(Non-covalent)

J2W.1: 15 residues within 4Å: Chain A: L.25, C.26, H.41, D.170, S.171, C.172, Q.173, S.176, V.190, W.192, G.193, N.194, I.195, C.197, G.204 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:Q.173, A:V.190 Hydrogen bonds: A:D.170, A:S.171, A:S.176, A:S.176 Water bridges: A:H.41, A:Q.173, A:Q.173, A:G.174, A:S.191, A:W.192, A:N.194, A:N.194

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

White, G.V. et al., Kallikrein 5 inhibitors identified through structure based drug design in search for a treatment for Netherton Syndrome. Bioorg. Med. Chem. Lett. (2019)

Release Date

2019-02-06

Peptides

Kallikrein-6: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Kallikrein-6

Related Entries With Identical Sequence